Adjuvant Treatment of Patients With High Risk of Recurrent Hepatocellular Carcinoma With Donafenib in Combination With Envafolimab
Clinical trial NCT06498622 · RECRUITING
Trial details
- NCT number
- NCT06498622
- Sponsor
- Anhui Provincial Hospital
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-07-20
- Primary completion
- 2027-05-20
- Enrollment
- 45
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.